Načítá se...
Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo
Metformin (N,N-dimethylbiguanidine) is a widely employed oral hypoglycemic agent for the management of type 2 diabetes mellitus. Its antioxidant properties and safe clinical use raise the possibility of preventing gentamicin-induced hearing loss in patients. Therefore, we screened the usefulness of...
Uloženo v:
| Vydáno v: | Neurosci Lett |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4253637/ https://ncbi.nlm.nih.gov/pubmed/25240593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.09.028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|